Focus Feature: New tool helps predict outcomes for COVID-19
A risk assessment tool developed by Kaiser Permanente researchers and physicians helps ensure patients get the right care, when they need it, by accurately predicting the probability that patients with COVID-19 symptoms will experience severe disease or even death.
R&E News and Features
Progression of children’s myopia may be influenced by race and ethnicity
Asian American children are at a much higher risk of a progression of myopia, commonly known as nearsightedness, new research shows.
People on dialysis have higher risk from COVID-19
Patients on dialysis have 18 times higher risk of hospitalization and death from COVID-19 than people who do not have end-stage kidney disease, new research shows.
Seeking early detection for pancreatic cancer
In a newly released video, Dr. Bechien Wu, MD, MPH, discusses what he and a team of physicians, biostatisticians, data scientists, epidemiologists, and radiologists are doing to improve early detection of pancreatic cancer.
Kaiser Permanente San Diego enrolling patients in monoclonal antibody trial
In November, emergency departments at the Kaiser Permanente San Diego and Zion medical centers began enrolling patients in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies trial.
In the News
Cardiomyopathy screenings low among young cancer survivors exposed to chest radiation or anthracyclines
Oncology Nurse AdvisorDecember 1, 2020Watch-and-wait appears safe and feasible for some patients with rectal cancer
Cancer NetworkNovember 12, 2020
Five questions...
for Dr. Chunyuan Qiu
Chunyuan Qiu, MD, MS, answers questions about his life and work as a clinician investigator for the Department of Research & Evaluation and the chief of the Department of Anesthesiology at Kaiser Permanente Baldwin Park Medical Center.